The 2022 update of the Canadian Stroke Best Practice Recommendations (CSBPR) for
Acute Stroke Management, 7th edition, is a comprehensive summary of current evidence …

Background: Though primarily a pulmonary disease, Coronavirus disease 2019 (COVID-19)
caused by the SARS-CoV-2 virus can generate devastating disease states that affect …

The SARS-CoV-2 infection causes COVID-19, which has affected approximately six hundred
million people globally as of 8 2022. Organs and cells harboring angiotensin-converting …

Background and Objectives Acute arterial ischemic stroke (AIS) has been reported as a rare
adverse event following coronavirus disease 2019 (COVID-19) vaccination with messenger …

Background Most case series of patients with ischemic stroke (IS) and COVID‐19 are limited
to selected centers or lack 3‐month outcomes. The aim of this study was to describe the …

Acute ischemic stroke (AIS) patients with active COVID-19 infection often have more severe
symptoms and worse recovery. COVID-19 infection can cause gut microbiota dysbiosis …

Introduction: The COVID-19 pandemic had an unprecedented global effect on teaching and
education. This review discusses research, education and diagnostics from the perspectives …

Background Although patients with COVID-19 have a higher risk of acute ischemic stroke
(AIS), the impact on stroke outcomes remains uncertain. Aims To determine the clinical …

Abstract Purpose of the Review Inflammation is a key component in the pathogenesis of
cerebrovascular diseases. In the past few years, the role of systemic infection and gut …

Objectives Cerebrovascular stroke (CVS) is one of the well-known complications of
coronavirus-2019 (Covid-19), but less is known about the outcome and safety of …